| Accession Number |
P01563 |
| For Use With (Application) |
Bioactivity |
| Formulation |
Protein with no preservative |
| Gene ID (Entrez) |
3440 |
| Molecular Weight (g/mol) |
19.2 kDa |
| Name |
Human IFN-alpha 2 (alpha 2b) (Carrier-Free) |
| Purification Method |
Purified |
| Quantity |
1 x 10^5 units |
| Storage Requirements |
-80°C |
| Regulatory Status |
RUO |
| Gene Alias |
alpha-2a interferon; IFNA; IFNA2; IFNA2A; IFNA2B; IFNA2C; IFN-alpha-2; IFN-alphaA; INFA2; Interferon; interferon alpha 2; interferon alpha 2a; interferon alpha 2b; interferon alpha A; interferon alpha-2; Interferon alpha-A; interferon, alpha 2; leIF A |
| Common Name |
Interferon alpha-2b |
| Gene Symbol |
IFNA2 |
| Biological Activity |
Specific Activity = 2.38 x 10e8 units/mg; Assay used to measure bioactivity: interferon was titrated with the use of the cytopathic effect inhibition assay as described [Rubinstein, S., Familletti, P.C., and Pestka, S. (1981'Convenient Assay for Interferons,'J. Virol. 37, 755-758; Familletti, P.C., Rubinstein, S., and Pestka, S. (1981)'A Convenient and Rapid Cytopathic Effect Inhibition Assay for Interferon,' in Methods in Enzymology, Vol. 78 (S. Pestka, ed.), Academic Press, New York, 387-394 ]. In this antiviral assay for interferon about 1 unit/mL of interferon is the quantity necessary to produce 50% cytopathic effect. The units are determined with respect to the international reference standard for human interferon alphaA (Hu-IFN-α? provided by the National Institutes of Health [see Pestka, S. (1986)'Interferon Standards and General Abbreviations,' in Methods in Enzymology, Vol. 119 (S. Pestka, ed.), Academic Press, New York, 14-23 ]. The activity was determined with bovine MDBK cells challenged with vesicular stomatitis virus (VSV). |
| Product Type |
Protein |
| Conjugate |
Unconjugated |
| Species |
Human |
| Recombinant |
Recombinant |
| Content And Storage |
-80°C |
| Activity |
Specific Activity = 2.38x10e8 units/mg; Assay used to measure bioactivity: interferon was titrated with the use of the cytopathic effect inhibition assay as described [Rubinstein, S., Familletti, P.C., and Pestka, S. (1981 Convenient Assay for Interferons, J. Virol. 37, 755-758; Familletti, P.C., Rubinstein, S., and Pestka, S. (1981) A Convenient and Rapid Cytopathic Effect Inhibition Assay for Interferon, in Methods in Enzymology, Vol. 78 (S. Pestka, ed.), Academic Press, New York, 387-394]. In this antiviral assay for interferon about 1 unit/mL of interferon is the quantity necessary to produce 50% cytopathic effect. The units are determined with respect to the international reference standard for human interferon alphaA (Hu-IFN-α? provided by the National Institutes of Health [see Pestka, S. (1986) Interferon Standards and General Abbreviations, in Methods in Enzymology, Vol. 119 (S. Pestka, ed.), Academic Press, New York, 14-23]. The activity was determined with bovine MDBK cells challenged with vesicular stomatitis virus (VSV). |
| Shipping Condition |
Dry Ice |
| Expression System |
E. coli |
| Protein Family |
Cytokines & Receptors |
| Protein Form |
Recombinant, Ligand |
| Form |
Liquid |
| Protein Subtype |
Interferons |
| Research Category |
Immunology, Virology, Oncology, Signal Transduction |
| Product Line |
Gibco |
| Purity or Quality Grade |
≥95% by SDS-PAGE |
|
Show More
Show Less
|
|